[Pharmacological studies on 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) as an anti-inflammatory agent].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001463:Barbiturates; D001777:Blood Coagulation / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D004487:Edema / Q000188:drug therapy; D005260:Female; D006099:Granuloma / Q000188:drug therapy; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D010538:Peritonitis / Q000188:drug therapy; D011743:Pyrimidines / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats
D000893:Anti-Inflammatory Agents; D001463:Barbiturates; D011743:Pyrimidines